Series B · Healthtech
CroíValve: Series B
Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease
Funding history
Series B · This round$27M
Loading rounds…
Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease